Anti-factor xa activity of standard and Japan-specific doses of rivaroxaban in thai patients with non-valvular atrial fibrillation

Anti-factor xa activity of standard and Japan-specific doses of rivaroxaban in thai patients with non-valvular atrial fibrillation

© 2020 Japanese Circulation Society. All rights reserved. Background: Recommended rivaroxaban doses for stroke prevention in atrial fibrillation (SPAF) are 20 and 15 mg/day in patients with normal and reduced renal function, respectively, but lower doses (15 and 10 mg) have been tested and approved...

Full description

Saved in:
Bibliographic Details
Main Authors: Wanwarang Wongcharoen, Phongsathon Pacharasupa, Lalita Norasetthada, Siriluck Gunaparn, Arintaya Phrommintikul
Format: Journal
Published: 2020
Subjects:
Medicine
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85087111274&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/70833
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University

Internet

https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85087111274&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/70833

Similar Items